Your browser version may not work well with NCBI's Web applications. More information here...
Items 1 - 20 of 125
of 7Next
1:

Lentiviral transduction of Tar Decoy and CCR5 ribozyme into CD34+ progenitor cells and derivation of HIV-1 resistant T cells and macrophages.

Banerjea A, Li MJ, Remling L, Rossi J, Akkina R.

AIDS Res Ther. 2004 Dec 17;1(1):2.

PMID: 15813986 [PubMed - as supplied by publisher]

2:

RNA-based anti-HIV-1 gene therapeutic constructs in SCID-hu mouse model.

Bai J, Banda N, Lee NS, Rossi J, Akkina R.

Mol Ther. 2002 Dec;6(6):770-82.

PMID: 12498773 [PubMed - indexed for MEDLINE]

3:

Safety and efficacy of a lentiviral vector containing three anti-HIV genes--CCR5 ribozyme, tat-rev siRNA, and TAR decoy--in SCID-hu mouse-derived T cells.

Anderson J, Li MJ, Palmer B, Remling L, Li S, Yam P, Yee JK, Rossi J, Zaia J, Akkina R.

Mol Ther. 2007 Jun;15(6):1182-8. Epub 2007 Apr 3.

PMID: 17406343 [PubMed - indexed for MEDLINE]

4:

CXCR4 and CCR5 shRNA transgenic CD34+ cell derived macrophages are functionally normal and resist HIV-1 infection.

Anderson J, Akkina R.

Retrovirology. 2005 Aug 18;2:53.

PMID: 16109172 [PubMed - indexed for MEDLINE]

5:

Characterization of anti-CCR5 ribozyme-transduced CD34+ hematopoietic progenitor cells in vitro and in a SCID-hu mouse model in vivo.

Bai J, Gorantla S, Banda N, Cagnon L, Rossi J, Akkina R.

Mol Ther. 2000 Mar;1(3):244-54.

PMID: 10933940 [PubMed - indexed for MEDLINE]

6:

Inhibition of HIV-1 by lentiviral vector-transduced siRNAs in T lymphocytes differentiated in SCID-hu mice and CD34+ progenitor cell-derived macrophages.

Banerjea A, Li MJ, Bauer G, Remling L, Lee NS, Rossi J, Akkina R.

Mol Ther. 2003 Jul;8(1):62-71.

PMID: 12842429 [PubMed - indexed for MEDLINE]

7:

siRNAs, ribozymes and RNA decoys in modeling stem cell-based gene therapy for HIV/AIDS.

Akkina R, Banerjea A, Bai J, Anderson J, Li MJ, Rossi J.

Anticancer Res. 2003 May-Jun;23(3A):1997-2005. Review.

PMID: 12894572 [PubMed - indexed for MEDLINE]

8:

Complete knockdown of CCR5 by lentiviral vector-expressed siRNAs and protection of transgenic macrophages against HIV-1 infection.

Anderson J, Akkina R.

Gene Ther. 2007 Sep;14(17):1287-97. Epub 2007 Jun 28.

PMID: 17597795 [PubMed - indexed for MEDLINE]

9:

Long-term inhibition of HIV-1 infection in primary hematopoietic cells by lentiviral vector delivery of a triple combination of anti-HIV shRNA, anti-CCR5 ribozyme, and a nucleolar-localizing TAR decoy.

Li MJ, Kim J, Li S, Zaia J, Yee JK, Anderson J, Akkina R, Rossi JJ.

Mol Ther. 2005 Nov;12(5):900-9. Epub 2005 Aug 22.

PMID: 16115802 [PubMed - indexed for MEDLINE]

10:

Multivalent anti-CCR ribozymes for stem cell-based HIV type 1 gene therapy.

Bai J, Rossi J, Akkina R.

AIDS Res Hum Retroviruses. 2001 Mar 20;17(5):385-99.

PMID: 11282007 [PubMed - indexed for MEDLINE]

11:

Inhibition of HIV-1 infection by lentiviral vectors expressing Pol III-promoted anti-HIV RNAs.

Li MJ, Bauer G, Michienzi A, Yee JK, Lee NS, Kim J, Li S, Castanotto D, Zaia J, Rossi JJ.

Mol Ther. 2003 Aug;8(2):196-206.

PMID: 12907142 [PubMed - indexed for MEDLINE]

12:

Derivation of normal macrophages from human embryonic stem (hES) cells for applications in HIV gene therapy.

Anderson JS, Bandi S, Kaufman DS, Akkina R.

Retrovirology. 2006 Apr 19;3:24.

PMID: 16623949 [PubMed - indexed for MEDLINE]

13:

Intracellular immunization of rhesus CD34+ hematopoietic progenitor cells with a hairpin ribozyme protects T cells and macrophages from simian immunodeficiency virus infection.

Rosenzweig M, Marks DF, Hempel D, Heusch M, Kraus G, Wong-Staal F, Johnson RP.

Blood. 1997 Dec 15;90(12):4822-31.

PMID: 9389699 [PubMed - indexed for MEDLINE]

14:

TRIM5alpharh expression restricts HIV-1 infection in lentiviral vector-transduced CD34+-cell-derived macrophages.

Anderson J, Akkina R.

Mol Ther. 2005 Oct;12(4):687-96.

PMID: 16081321 [PubMed - indexed for MEDLINE]

15:

HIV-1 resistance conferred by siRNA cosuppression of CXCR4 and CCR5 coreceptors by a bispecific lentiviral vector.

Anderson J, Akkina R.

AIDS Res Ther. 2005 Jan 13;2(1):1.

PMID: 15813990 [PubMed - as supplied by publisher]

16:

Lentivirus-mediated transduction of PKR into CD34(+) hematopoietic stem cells inhibits HIV-1 replication in differentiated T cell progeny.

Dimitrova DI, Yang X, Reichenbach NL, Karakasidis S, Sutton RE, Henderson EE, Rogers TJ, Suhadolnik RJ.

J Interferon Cytokine Res. 2005 Jun;25(6):345-60.

PMID: 15957958 [PubMed - indexed for MEDLINE]

17:

T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery.

Swan CH, Bühler B, Steinberger P, Tschan MP, Barbas CF 3rd, Torbett BE.

Gene Ther. 2006 Oct;13(20):1480-92. Epub 2006 Jun 1. Erratum in: Gene Ther. 2007 Apr;14(7):626. Steinberger, P [added].

PMID: 16738691 [PubMed - indexed for MEDLINE]

18:

Ex vivo selection and expansion of cells based on expression of a mutated inosine monophosphate dehydrogenase 2 after HIV vector transduction: effects on lymphocytes, monocytes, and CD34+ stem cells.

Yam P, Jensen M, Akkina R, Anderson J, Villacres MC, Wu J, Zaia JA, Yee JK.

Mol Ther. 2006 Aug;14(2):236-44. Epub 2006 May 2.

PMID: 16647299 [PubMed - indexed for MEDLINE]

19:

Transduction of human hematopoietic stem cells by lentiviral vectors pseudotyped with the RD114-TR chimeric envelope glycoprotein.

Di Nunzio F, Piovani B, Cosset FL, Mavilio F, Stornaiuolo A.

Hum Gene Ther. 2007 Sep;18(9):811-20.

PMID: 17824830 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 125
of 7Next